Abstract
A newly synthesized calmodulin antagonist, DY9760e (3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1(-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate), has been shown to possess a cytoprotective effect against cytotoxicity induced by Ca2+ overload [1]. Since Ca2+ overload is suspected to be one of the major causes of ischemic neuronal cell damage [2], we examined the effect of this drug on infarct volume in the rat permanent focal ischemia model.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Sugimura M, Sato T, Nakayama W, Morishima Y, Fukunaga K, Omitsu M, Miyamoto E, Shirasaki Y (1997) DY-9760e, a novel calmodulin antagonist with cytoprotective action. Eur J Pharmacol 336: 99–106
Siesjö BK, Bengtsson F (1989) Calcium fluxes, calcium antagonists, and calcium-related pathology in brain ischemia, hypoglycemia, and spreading depression: a unifying hypothesis. J Cereb Blood Flow Metab 9: 127–190
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Takagi, K. et al. (1999). The Protective Effect of DY9760e, a Novel Calmodulin Antagonist, on Rat Permanent Middle Cerebral Artery Occlusion. In: Ito, U., Fieschi, C., Orzi, F., Kuroiwa, T., Klatzo, I. (eds) Maturation Phenomenon in Cerebral Ischemia III. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-58602-6_36
Download citation
DOI: https://doi.org/10.1007/978-3-642-58602-6_36
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-65023-2
Online ISBN: 978-3-642-58602-6
eBook Packages: Springer Book Archive